Loading...
•
Jun 30, 2020
Merit Medical Q2 2020 Earnings Report
Merit Medical experienced a revenue decline but demonstrated progress in strategic goals and free cash flow generation.
Key Takeaways
Merit Medical reported a decrease in revenue for Q2 2020, with a worldwide revenue of $218.4 million, a (14.5)% decrease compared to Q2 2019. The company reported a GAAP loss per share of $(0.34) and a non-GAAP EPS of $0.31. Despite the revenue decline, the company generated $32 million in free cash flow and continued progress on strategic goals.
Worldwide revenue decreased by (14.5)% to $218.4 million compared to Q2 2019.
Core revenue on a constant currency basis decreased by (13.6)% compared to Q2 2019.
GAAP loss per share was $(0.34), compared to GAAP EPS of $0.12 in Q2 2019.
Non-GAAP EPS was $0.31, compared to $0.42 in Q2 2019.
Revenue by Segment
Forward Guidance
Due to the general uncertainty and rapidly changing global environment related to the COVID-19 pandemic and corresponding economic downturn, Merit’s management has concluded that it cannot issue financial guidance for the remainder of 2020.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...